Exploring Long-Acting Injectable Buprenorphine

12-1pm

Click Here or Scan the QR Code to Register

This webinar is designed to equip healthcare teams with essential information on FDA-approved monthly and weekly injectable buprenorphine formulations for the treatment of opioid use disorder, along with guidance on integrating them into clinical practice. Key topics will include the pharmacology, side effects, and storage of injectable buprenorphine, as well as the administration process, patient selection criteria, and dosage recommendations. The session will also cover the initiation and maintenance of treatment for patients using these injectable formulations, along with the workflows and administrative tasks involved in implementing injectable buprenorphine in healthcare settings.

Learning Objectives:

• Describe the different available long-acting injectable buprenorphine formulations and their dosing schedules.
• Review current regulations related to prescribing and dispensing long-acting injectable buprenorphine.
• Describe key considerations in determining patient eligibility for long-acting injectable buprenorphine
• Compare the pros and cons of Sublocade and Brixadi in terms of patient selection
• Explain the process of initiating and transitioning patients to long-acting injectable buprenorphine.

1 CE Credit (1.0 hour):

• CME (pending)
• MCBAP
• Social Work
• Meets DEA Training Requirements

Presenters:

• Greg Jones, MD
• Mike Kates, DO